Apexium Financial LP Reduces Holdings in iShares Biotechnology ETF $IBB

Apexium Financial LP reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 18.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,625 shares of the financial services provider’s stock after selling 3,082 shares during the period. Apexium Financial LP’s holdings in iShares Biotechnology ETF were worth $1,724,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Moors & Cabot Inc. lifted its position in iShares Biotechnology ETF by 2.0% in the first quarter. Moors & Cabot Inc. now owns 29,053 shares of the financial services provider’s stock valued at $3,716,000 after buying an additional 558 shares during the last quarter. IFP Advisors Inc lifted its holdings in shares of iShares Biotechnology ETF by 23.9% in the 1st quarter. IFP Advisors Inc now owns 19,849 shares of the financial services provider’s stock worth $2,539,000 after acquiring an additional 3,831 shares during the last quarter. N.E.W. Advisory Services LLC acquired a new position in shares of iShares Biotechnology ETF in the 1st quarter worth approximately $45,000. Kingswood Wealth Advisors LLC lifted its holdings in shares of iShares Biotechnology ETF by 81.2% in the 1st quarter. Kingswood Wealth Advisors LLC now owns 4,532 shares of the financial services provider’s stock worth $570,000 after acquiring an additional 2,031 shares during the last quarter. Finally, John G Ullman & Associates Inc. acquired a new position in shares of iShares Biotechnology ETF in the 1st quarter worth approximately $230,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $151.00 on Friday. The firm’s 50 day moving average price is $139.19 and its 200-day moving average price is $130.00. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $151.62.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were issued a $0.0828 dividend. This represents a $0.33 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.